跳至主要内容
临床试验/NCT06384703
NCT06384703已完成不适用

The Evaluation of the Relationship Between Coronary Ectasia And Trimethylamine N Oxide

Konya Beyhekim Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2020年11月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2
试验地点
1
主要终点
death

研究概览

简要总结

Introduction: It is now known that the microbiota is far beyond the microbial communities living in certain parts of our body and functions like a metabolic organ. In addition, the microbiota, through its metabolites, is involved in the pathophysiology or progression of a wide range of diseases, from atherosclerotic diseases to metabolic diseases and even neurological diseases. Among these metabolites, trimethylamine n-oxide metabolite has been shown to be particularly effective on atherosclerotic heart diseases.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • over 18 years old
  • not having occlusive coronary artery disease
  • having coronary ectasia

排除标准

  • patients with chronic kidney disease,
  • revascularized coronary artery disease,
  • previously documented critical coronary stenosis,
  • acute or chronic inflammatory disease,
  • rheumatologic disease,
  • known active malignant disease,
  • heart failure,
  • moderate-to-severe valvular pathology
  • patients who were on any steroid or immunosuppressive therapy

结局指标

主要结局

death

时间窗: 1 month

Death from any cause within the last month

次要结局

未报告次要终点

研究者

发起方
Konya Beyhekim Training and Research Hospital
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验